<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04023825</url>
  </required_header>
  <id_info>
    <org_study_id>PI2018_843_0020</org_study_id>
    <nct_id>NCT04023825</nct_id>
  </id_info>
  <brief_title>Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children</brief_title>
  <acronym>Suprazyg</acronym>
  <official_title>Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a monocentric prospective randomized simple-blind designed study evaluating the
      superiority of the suprazygomatic maxillary nerve block in analgesia after cleft palate
      surgery compared with a control group. Every two hours, nurses systematically reassess the
      patient's pain and adjust the analgesic medications. Analgesic requirement, incidence of
      respiratory complications, re-feeding time and the duration of hospitalization are evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cleft palate is the most common congenital malformation and requires early surgery given the
      complications it generates. The surgical site involving the upper airways and the use of
      morphine are providers of respiratory complications. The suprazygomatic maxillary nerve block
      could considerably reduce the use of morphine in the postoperative period and thus the
      respiratory complications in addition to an optimal comfort for the patient. The primary
      endpoint was to evaluate morphine consumption during the first postoperative 48 hours after
      cleft palate surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2019</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline of morphine consumption</measure>
    <time_frame>up to 48 hours after cleft palate surgery</time_frame>
    <description>The main objective of this study is to compare the consumption of morphine during the first 48 hours after cleft palate surgery in a group of patients treated by realization of a suprazygomatic maxillary nerve block, compared to a control group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline of consumption of perioperative morphine</measure>
    <time_frame>up to one week after cleft palate surgery</time_frame>
    <description>evaluation of the consumption of perioperative morphine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of the number of episodes of respiratory distress</measure>
    <time_frame>up to one week after cleft palate surgery</time_frame>
    <description>Measure of the number of episodes of respiratory distress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of the period of re-feeding</measure>
    <time_frame>up to one week after cleft palate surgery</time_frame>
    <description>Measure of the period of re-feeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of the duration of hospitalization</measure>
    <time_frame>up to one week after cleft palate surgery</time_frame>
    <description>Measure of the duration of hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Cleft Palate</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive loco regional anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will not receive loco regional anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>suprazygomatic maxillary nerve block</intervention_name>
    <description>in the experimental group, each child will profit from the realization of a suprazygomatic maxillary nerve block.</description>
    <arm_group_label>experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children between 5 months and 12 years old

          -  weight &gt;5kg

          -  children undergoing cleft palate repair surgery with or without upper lip surgery

        Exclusion Criteria:

          -  inappropriate age

          -  weight &lt;5kg

          -  abnormal blood coagulation

          -  local anesthetic contraindication (including levobupivacaine, as well as any other
             associated treatment administered in this clinical study, including opioids, general
             anesthetics such as ketamine or propofol, paracetamol or corticosteroids)

          -  local infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthieu Miclo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emmanuel Lorne, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jérémie Garnier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie Trujillo-Garcia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dimitri Santarelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cica Carole Gbaguidi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthieu Miclo, MD</last_name>
    <phone>(33)322087974</phone>
    <email>miclo.matthieu@chu-amiens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuel Lorne, Pr</last_name>
    <phone>(33)322087980</phone>
    <email>lorne.emmanuel@chu-amiens.fr</email>
  </overall_contact_backup>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 16, 2019</study_first_submitted>
  <study_first_submitted_qc>July 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2019</study_first_posted>
  <last_update_submitted>July 16, 2019</last_update_submitted>
  <last_update_submitted_qc>July 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cleft palate</keyword>
  <keyword>surgery</keyword>
  <keyword>maxillary nerve block</keyword>
  <keyword>local anesthetic</keyword>
  <keyword>loco regional anesthesia</keyword>
  <keyword>face nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cleft Palate</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

